# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T16:07:17.333862
**Route:** Direct Google API + PDF
**Paper Hash:** e15dcbe497842dce
**Tokens:** 22998 in / 614 out
**Response SHA256:** 79b7fc7c2599fd1b

---

I have reviewed the draft paper "The Depleted Safety Net: Hysteresis in Medicaid’s Home Care Workforce" for fatal errors.

**ADVISOR REVIEW**

**1. DATA-DESIGN ALIGNMENT: NO ERRORS**
- The treatment variable (pre-COVID exit rate) is constructed using data from 2018–2019. The outcome data covers 2018–2024. The temporal ordering is correct: the "treatment" is measured entirely before the pandemic shock (March 2020) and the subsequent evaluation period.
- RDD/DiD requirements: The event studies (Figures 2 and 4) show data on both sides of the March 2020 cutoff and the April 2021 ARPA cutoff.

**2. REGRESSION SANITY: NO ERRORS**
- Standard Errors: SEs in Tables 3, 4, 5, and 6 are within reasonable bounds (generally 0.04 to 0.50) for log-transformed outcomes. There are no instances of SE > 1000 or SE > 100 × coefficient.
- Coefficients: Coefficients for log outcomes are generally between -1.5 and +0.5, which is plausible.
- Impossible Values: $R^2$ values are between 0.89 and 0.98, which is high but typical for state-level panels with state and month fixed effects. No negative SEs or "NaN" values were found in the results tables.

**3. COMPLETENESS: NO ERRORS**
- Regression tables (Tables 3, 4, 5, 6) include observation counts (N) and standard errors.
- There are no "TBD" or "PLACEHOLDER" entries in the tables.
- All figures (1–10) mentioned in the text are present and correctly numbered.

**4. INTERNAL CONSISTENCY: NO ERRORS**
- Numbers Match: Statistics cited in the abstract (6% supply decline, 7% access decline) match the coefficients reported in the text and Table 3 ($0.073 \times 0.879 \approx 0.064$ for providers; $0.073 \times 1.005 \approx 0.073$ for beneficiaries).
- Timing Consistency: The treatment timing (March 2020 for COVID, April 2021 for ARPA) is applied consistently across all event studies and regression tables.
- Sample Consistency: The sample size of 4,284 in Table 3 (HCBS only) correctly doubles to 8,568 in Table 5 (HCBS + Non-HCBS), reflecting the inclusion of the comparison group.

**ADVISOR VERDICT: PASS**